Chem. J. Chinese Universities ›› 2015, Vol. 36 ›› Issue (9): 1694.doi: 10.7503/cjcu20150404

• Organic Chemistry • Previous Articles     Next Articles

Design and Synthesis of Phenylpyrimidine and Their Anticancer Activity

ZHOU Hao, DUAN Zhigang, ZHAO Shuang, BAO Meiying, LI Zhiwei*(), PEI Yazhong*()   

  1. Center for Combinatorial Chemistry and Drug Discovery, School of Pharmaceutical Sciences,Jilin University, Changchun 130021, China
  • Received:2015-05-20 Online:2015-09-10 Published:2015-08-21
  • Contact: LI Zhiwei,PEI Yazhong E-mail:zwl.jida@gmail.com;peiyz@jlu.edu.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.81172914, 81071743), the Tang Aoqing Professorship Research Grant from Jilin University, China and the Jilin Province Talent Development Program, China

Abstract:

Allosteric kinase inhibitors modulate kinase activities by inducing and stabilizing the inactive conformations of the targets. In comparison to ATP competitive inhibitors, this type inhibitors exhibit better selectivity and higher efficacy, and have shown to be safe and effective treatments for various forms of cancers in the clinics. Based on the X-ray co-crystal structures of reported allosteric kinase inhibitors bound to thecorresponding protein kinases, a bi-cyclic pharmacophore model was proposed. 19 new phenylpyrimidine derivatives were designed and synthesized from 2,4-diamino-5-methylpyrimidine. The inhibitory effects of these compounds against human breast cancer cell(MCF-7) proliferation were evaluated using MTT method. The leader compounds, 8c and 9c, were identified showing IC50 of 0.224 and 0.113 μmol/L, respectively.

Key words: Phenylpyrimidine, Protein kinase, Allosteric kinase inhibitor, Antitumor activity

CLC Number: 

TrendMD: